Delivery Order VA69D17D0031-36C25220N0125

The Department of Veterans Affairs Veterans Health Administration awarded a $5,984 firm fixed price delivery order to Myriad Genetic Laboratories Inc. for ProLaris testing. The parent company of the prime contractor is Myriad Genetics Inc. The single award was made on December 1, 2021 with a completion date of November 30, 2022. The place of performance is located in Emigration Canyon, Utah. No set aside designation was used for this contract to provide genetic testing services through the VHA's...

The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order contract valued at one hundred thirty-two thousand four hundred fifty-five dollars and ninety-one cents ($132,455.91) to Myriad Genetics Inc. to provide Prolaris testing services in support of prostate cancer diagnostics for the VA Long Beach Healthcare System located in Long Beach, California. The contract calls for the contractor to perform quantitative PCR analysis on prostate biopsy...

This federal contract award with ID HT001417A0029|HT001419F0321 was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company, for Myriad's Prolaris genetic testing services. The $100,000.00 firm-fixed-price contract is for quantitative PCR analysis and reporting to assess prostate cancer aggressiveness and guide treatment approaches. This appears to be a Blanket Purchase Agreement (BPA) call, with Myriad Genetics having been awarded multiple prior BPA calls...

This federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration was granted to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to provide Prolaris prostate cancer testing services. The firm fixed price contract, valued at $14,994.00, is a Blanket Purchase Agreement (BPA) call to support disease risk stratification and treatment planning for veterans served by the VA's Veterans Integrated Service Network (VISN) 19 in Salt Lake...

This is a firm fixed price delivery order awarded to Myriad Genetic Laboratories Inc., a leading genetic testing and precision medicine company, by the Department of Veterans Affairs (VA) Veterans Health Administration. The $10,982 contract is for the provision of Prolaris prostate cancer testing services to support disease risk stratification and treatment planning for veterans served by the VA's Veterans Integrated Service Network 12. Myriad Genetic Laboratories previously held a $149,600...

This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Myriad RBM, Inc., a subsidiary of Myriad Genetics, Inc. The $10,157.40 contract is for the provision of Myriad's Prolaris quantitative PCR testing services to assess prostate cancer tumor aggressiveness and guide treatment approaches. No set-aside designation was mentioned. Myriad Genetics, a...

This federal contract award was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company headquartered in Salt Lake City, Utah. The $100,000.00 firm-fixed-price contract is for MYRIAD GENETIC TESTING services, specifically the company's ProLaris testing for prostate cancer. The contract has no set-aside designation, indicating open competition. This award is part of Myriad Genetics Inc.'s ongoing work providing specialized genetic testing services,...

This is a firm fixed-price purchase order awarded by the Defense Health Agency to Propath Services, LLC, a nationwide pathology practice that provides patient-centered medical diagnostics, prognostic assessments, and related services. The contract is for $125,000.00 and is for specialized laboratory studies and tests. This award is not a set-aside. Propath Services has previously provided services such as immunochemistry stains analysis, interpretation services, dermatopathology diagnostic...

This is a firm fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Propath Services, LLC, a for-profit organization, for the provision of analysis services for inconclusive biopsies. The contract has a ceiling value of $80,000.00 and an ultimate completion date of September 30, 2017. This contract award is not associated with a larger contract vehicle and does not have a set-aside designation. Propath Services, LLC is a nationwide pathology practice that...

This is a firm fixed price contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of THROSEQ V.2 molecular testing services. The contract has a potential value of $395,000.00 and a completion date of December 15, 2020. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and diagnosis utilizing next generation genomic...